UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
NIBEC wins patent for peptide-based inducible pluripotent stem cell in US
Nano Intelligence Biomedical Engineering Corporation (NIBEC) has acquired a...
by Lee Han-soo
|
2018-07-04 13:30
라인
Biopharma stocks listed in H1 perform poorer than non-pharma peers
Pharmaceutical and biotech companies listed in the first half marked a slow...
by Nam Doo-hyun
|
2018-07-03 15:08
라인
Beijing Northland to go ahead with P3 clinical trials for VM202 in China
Viromed said Friday that Beijing Northland Biotech, its Chinese partner, wi...
by Lee Han-soo
|
2018-06-29 15:44
라인
Biogen purchases Samsung Bioepis’ share
Samsung BioLogics said Friday that Biogen has exercised its call option and...
by Lee Han-soo
|
2018-06-29 14:23
라인
LG Chem launches Enbrel biosimilar in Korea
LG Chem said Wednesday that it has launched Eucept, an Enbrel biosimilar (i...
by Lee Han-soo
|
2018-06-28 12:23
라인
Prognostic marker for childhood obesity complications wins patent
A new biomarker in urine to predict childhood obesity complications might b...
by Nam Doo-hyun
|
2018-06-27 12:19
라인
Antarctic sea microorganisms; a solution to blood shortage?
The Korean government has developed a technology to freeze human blood usin...
by Nam Doo-hyun
|
2018-06-26 14:44
라인
Over 60% of KOSDAQ biotech firms mark falls in Q1 operating profit
More than 60 percent of biotech companies listed on KOSDAQ suffered operati...
by Nam Doo-hyun
|
2018-06-19 11:43
라인
Celltrion completes FDA resubmission for Trastuzumab biosimilar
Celltrion said Monday that it has resubmitted the application to obtain mar...
by Lee Han-soo
|
2018-06-18 17:43
라인
Oral care probiotics research on rise
Domestic microbiome firms such as Bifido are entering the oral care probiot...
by Marian Chu
|
2018-06-18 15:20
라인
SCM, Toolgen to develop new stem cell treatment
SCM Lifescience said Thursday that it has signed a memorandum of understand...
by Lee Han-soo
|
2018-06-15 15:21
라인
NIBEC wins to stem cell regeneration patent
Nano Intelligence Biomedical Engineering Corporation (NIBEC) has acquired a...
by Lee Han-soo
|
2018-06-15 14:43
라인
Nature Cell suspected of manipulating stock prices
The Seoul Southern District Prosecutor's Office recently raided the hea...
by Lee Han-soo
|
2018-06-12 17:54
라인
Celltrion launches new business platform
Celltrion will announce its plan to launch a bio contract development and m...
by Lee Han-soo
|
2018-06-05 17:49
라인
Bio group takes part in US investment conference
Korea Biotechnology Industry Organization (Korea BIO) said Monday that it i...
by Lee Han-soo
|
2018-06-04 16:14
라인
Nature Cell applies for P3 clinical trials
Nature Cell said Friday that Biostar, its stem cell research institution, h...
by Lee Han-soo
|
2018-06-01 15:43
라인
Biosimilars quickly catch up with originals in Korea
Korean biosimilar drugs are quickly chasing original medicines in the domes...
by So Jae-hyeon
|
2018-06-01 15:37
라인
Korean biosimilar makers tap into Japan
Korean manufacturers of biosimilar products are making a foray into Japan, ...
by So Jae-hyeon
|
2018-05-30 15:41
라인
LG Chem launches Enbrel biosimilar in Japan
LG Chem said Wednesday that it has launched Etanercept BS [MA], an Enbrel b...
by Lee Han-soo
|
2018-05-30 14:31
라인
Will biotech stocks rebound on listings in H2?
The biotech industry is paying attention to whether upcoming initial public...
by So Jae-hyeon
|
2018-05-30 11:33
-
이전
11
12
13
14
15
16
17
18
19
20
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top